carbostyril has been researched along with Dermatitis Medicamentosa in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (23.53) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 6 (35.29) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Breneman, A; Gallitano, SM; Soliman, YS | 1 |
| Baek, SW; Lee, HJ; Seo, YJ | 1 |
| Chiu, CH; Chung, WH; Hu, HC; Huang, CT; Hung, SI; Kao, KC; Lin, JY; Lin, YF; Rosaline Hui, CY; Sindy, H; Tsai, YC; Wu, TS; Yang, CH | 1 |
| Concellón, MA; Gracia-Cazaña, T; Grasa-Jordán, MP; Pastushenko, I | 1 |
| Beasley, K; Dalton, SR; Kimes, K | 1 |
| Borja Segade, J; Castro Jiménez, A; Feo Brito, FJ; Galindo Bonilla, PA; García Rodríguez, R; Gómez Torrijos, E; Lara de la Rosa, P | 1 |
| Blanca, M; Thong, BY | 1 |
| Albitar, M; Cortes, J; Garcia-Manero, G; Giles, F; Kantarjian, H; Koller, C; Kurzrock, R; O'Brien, S; Rackoff, W; Talpaz, M; Thibault, A; Thomas, D | 1 |
| Iwamura, H; Kaya, T; Matsui, T; Miyagawa, N; Ueda, Y | 1 |
| Caruso, C; Gaeta, F; Quaratino, D; Romano, A; Rumi, G; Valluzzi, RL; Viola, M | 1 |
| Arceci, RJ; Balis, FM; Blaney, SM; End, D; Fox, E; Gillespie, A; Jayaprakash, N; Palumbo, JS; Pitney, A; Salzer, WL; Whitcomb, P; Widemann, BC; Zannikos, P | 1 |
| Bavinck, JN; Dunant, A; Fagot, JP; Halevy, S; Mockenhaupt, M; Naldi, L; Roujeau, JC; Sidoroff, A; Viboud, C | 1 |
| Kubota, K; Kubota, N; Mann, RD; Pearce, GL; Prescott, P | 1 |
| Landor, M; Lashinsky, A; Waxman, J | 1 |
| Hamanaka, H; Mizutani, H; Shimizu, M | 1 |
| Benito, RP; Cócera, CM; Llamazares, AA; Rodríguez-Morales, A | 1 |
1 review(s) available for carbostyril and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Allergic reactions to antibiotics, mainly betalactams: facts and controversies.
Topics: Anti-Bacterial Agents; beta-Lactams; Cross Reactions; Drug Eruptions; Drug Hypersensitivity; Enzyme-Linked Immunosorbent Assay; Humans; Immunoglobulin E; Intradermal Tests; Lymphocyte Activation; Macrolides; Quinolones; Radioallergosorbent Test; Sulfonamides; T-Lymphocyte Subsets | 2005 |
2 trial(s) available for carbostyril and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Efficacy of the farnesyl transferase inhibitor R115777 in chronic myeloid leukemia and other hematologic malignancies.
Topics: Adult; Aged; Alkyl and Aryl Transferases; Antineoplastic Agents; Blast Crisis; Drug Administration Schedule; Drug Eruptions; Endothelial Growth Factors; Enzyme Inhibitors; Farnesyltranstransferase; Fatigue; Female; Fibroblast Growth Factor 2; Hepatocyte Growth Factor; Humans; Intercellular Signaling Peptides and Proteins; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Accelerated Phase; Leukemia, Myeloid, Chronic-Phase; Lymphokines; Male; Middle Aged; Multiple Myeloma; Nausea; Neoplasm Proteins; Primary Myelofibrosis; Quinolones; Salvage Therapy; Treatment Outcome; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
Phase I trial and pharmacokinetic study of the farnesyltransferase inhibitor tipifarnib in children with refractory solid tumors or neurofibromatosis type I and plexiform neurofibromas.
Topics: Adolescent; Antineoplastic Agents; Bone Marrow; Child; Child, Preschool; Drug Administration Schedule; Drug Eruptions; Enzyme Inhibitors; Farnesyltranstransferase; Female; Gastrointestinal Tract; Humans; Male; Neurofibroma, Plexiform; Neurofibromatosis 1; Quinolones; Treatment Outcome | 2006 |
14 other study(ies) available for carbostyril and Dermatitis Medicamentosa
| Article | Year |
|---|---|
An acneiform eruption associated with elexacaftor/tezacaftor/ivacaftor treatment.
Topics: Acneiform Eruptions; Adult; Aminophenols; Benzodioxoles; Chloride Channel Agonists; Cystic Fibrosis; Drug Combinations; Drug Eruptions; Humans; Indoles; Male; Pyrazoles; Pyridines; Pyrrolidines; Quinolones | 2021 |
Multiple milia associated with use of the tyrosine kinase inhibitor dovitinib.
Topics: Antineoplastic Agents; Benzimidazoles; Drug Eruptions; Humans; Keratosis; Male; Middle Aged; Prostatic Neoplasms; Protein Kinase Inhibitors; Quinolones | 2018 |
Severe cutaneous adverse reactions related to systemic antibiotics.
Topics: Acute Generalized Exanthematous Pustulosis; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Drug Eruptions; Eosinophilia; Female; Glycopeptides; Humans; Male; Middle Aged; Penicillins; Quinolones; Retrospective Studies; Stevens-Johnson Syndrome; Taiwan | 2014 |
A comedonal acneiform eruption following dovitinib therapy.
Topics: Acneiform Eruptions; Antineoplastic Agents; Benzimidazoles; Drug Eruptions; Humans; Male; Middle Aged; Protein Kinase Inhibitors; Quinolones | 2014 |
Eruptive milia and comedones during treatment with dovitinib.
Topics: Antineoplastic Agents; Benzimidazoles; Drug Eruptions; Facial Dermatoses; Gastrointestinal Neoplasms; Humans; Keratosis; Male; Middle Aged; Miliaria; Quinolones | 2015 |
Chronic desensitization to quinolones in fixed drug eruption.
Topics: Adult; Ciprofloxacin; Cystic Fibrosis; Desensitization, Immunologic; Drug Eruptions; Erythema; Female; Humans; Pipemidic Acid; Quinolones | 2011 |
Allergic drug reactions: from basic research to clinical practice.
Topics: Animals; Dendritic Cells; Diagnostic Uses of Chemicals; Drug Eruptions; Drug Hypersensitivity; Humans; Hypersensitivity, Delayed; Immunity, Innate; Pharmaceutical Preparations; Proteomics; Quinolones | 2011 |
Involvement of cannabinoid CB(2) receptor-mediated response and efficacy of cannabinoid CB(2) receptor inverse agonist, JTE-907, in cutaneous inflammation in mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Area Under Curve; Camphanes; Cannabinoids; Dinitrofluorobenzene; Dioxoles; Disease Models, Animal; Drug Eruptions; Ear, External; Female; Indomethacin; Inflammation; Lymph Nodes; Mice; Mice, Inbred BALB C; Pyrazoles; Quinolones; Receptor, Cannabinoid, CB2; RNA, Messenger; Time Factors | 2005 |
Risk factors for acute generalized exanthematous pustulosis (AGEP)-results of a multinational case-control study (EuroSCAR).
Topics: Anti-Infective Agents; Austria; Calcium Channel Blockers; Case-Control Studies; Diltiazem; Drug Eruptions; Exanthema; Female; France; Humans; Hydroxychloroquine; Israel; Italy; Male; Middle Aged; Naphthalenes; Netherlands; Penicillins; Pristinamycin; Quinolones; Risk Factors; Sulfonamides; Terbinafine | 2007 |
Signalling drug-induced rash with 36 drugs recently marketed in the United Kingdom and studied by Prescription-Event Monitoring.
Topics: Adult; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Agents; Central Nervous System Agents; Cohort Studies; Drug Eruptions; Drug Prescriptions; Female; Histamine Antagonists; Humans; Male; Middle Aged; Product Surveillance, Postmarketing; Quinolones; Skin; United Kingdom | 1995 |
Quinolone allergy?
Topics: Biopsy; Ciprofloxacin; Dermatitis Herpetiformis; Diagnosis, Differential; Drug Eruptions; Drug Hypersensitivity; Erythema Multiforme; Humans; Male; Middle Aged; Pemphigoid, Bullous; Quinolones; Skin | 1996 |
Sparfloxacin and levofloxacin.
Topics: Administration, Oral; Anti-Infective Agents; Bronchitis; Chronic Disease; Clinical Trials as Topic; Drug Eruptions; Fluoroquinolones; Gastrointestinal Diseases; Humans; Levofloxacin; Ofloxacin; Photosensitivity Disorders; Pneumonia; Quinolones | 1997 |
Sparfloxacin-induced photosensitivity and the occurrence of a lichenoid tissue reaction after prolonged exposure.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Drug Eruptions; Female; Fluoroquinolones; HLA-DR Antigens; Humans; Immunohistochemistry; Intercellular Adhesion Molecule-1; Lichenoid Eruptions; Male; Middle Aged; Photosensitivity Disorders; Quinolones; Skin | 1998 |
Fixed drug eruption from quinolones with a positive lesional patch test to ciprofloxacin.
Topics: Adult; Ciprofloxacin; Drug Eruptions; Female; Hand Dermatoses; Humans; Patch Tests; Quinolones; Skin | 2001 |